Predicting outcomes after hip fracture using MDW
Part of Infections, Injuries & trauma clinical trials.
This trial checks if a blood test called MDW (monocyte distribution width) can help predict complications and recovery in older adults after a hip fracture.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You broke your hip from a simple fall (not from a car accident or high impact).
- You are being treated at the General Hospital of Attica KAT.
- Your doctor can get your routine blood test results including MDW and other inflammation markers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how frailty and inflammation affect recovery after a hip fracture in older adults. It aims to find biomarkers that could help personalize care.
This study looks at whether a simple score (Nottingham Hip Fracture Score) and a frailty check can help predict survival after hip fracture surgery. It aims to help doctors better understand risks for older adults who need hip surgery.
This study looks at how decisions are made for older patients with hip fractures who are also frail. It aims to improve shared decision-making between patients, families, and doctors, so patients can be more involved in their care choices.
This study looks at a simple blood test called CALLY (CRP-Albumin-Lymphocyte) to see if it can predict which older adults might become confused after hip fracture surgery. The goal is to identify those at risk early so doctors can take steps to prevent or manage delirium.
This study checks if the size of a thigh muscle and a nutrition score can help predict recovery in older patients having hip fracture surgery. It might help doctors plan better care after surgery.
This study looks at older adults who break their hip and are admitted to the hospital. It aims to find out what factors affect whether they survive their hospital stay, which can help improve care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.